Skip to content

13F-HR filed by Melqart Asset Management (UK) Ltd

Melqart Asset Management (UK) Ltd filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-15, with 32 holding rows worth $1,077,339,000.

Accession
0001172661-19-001325
Filed
2019-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2019

A holdings report, 32 entries on the cover page, a total value of $1,077,339,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,077,339,000 with VALUE read as thousands by filing date, 13F file number 028-18520. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CELGENE CORP151020104COM1,376,500$129,859,000thousands by filing date
NXP SEMICONDUCTORS N V COMN6596X109Stock1,300,000$114,907,000thousands by filing date
Walt Disney Co254687106COM970,000$107,699,000thousands by filing dateput
RED HAT INC756577102COM350,769$64,085,000thousands by filing date
THE ULTIMATE SOFTWARE GROUP IN90385D107COM192,000$63,385,000thousands by filing date
UNITED STATES OIL FUND LP91232N108UNITS4,000,000$50,000,000thousands by filing dateput
CONTURA ENERGY INC21241B100COM782,811$45,340,000thousands by filing date
QIWI PLC74735M108SPON ADR REP B2,538,615$36,531,000thousands by filing date
ARRIS INTL INC SHSG0551A103SHS1,143,491$36,146,000thousands by filing date
WABCO HLDGS INC92927K102COM259,200$34,170,000thousands by filing date
VERSUM MATLS INC92532W103COM658,363$33,122,000thousands by filing date
CELGENE CORP151020104COM321,000$30,283,000thousands by filing dateput
TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS874060205ADR1,481,137$30,171,000thousands by filing date
ATLANTICA YIELD PLCG0751N103SHS1,474,615$28,696,000thousands by filing date
Bristol-Myers Squibb Company110122108COM572,000$27,052,000thousands by filing datecall
SPARK THERAPEUTICS INC84652J103COM222,000$25,281,000thousands by filing date
Walt Disney Co254687106COM226,007$25,094,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM132,500$24,373,000thousands by filing date
TRAVELPORT WORLDWIDE LTDG9019D104SHS1,439,435$22,642,000thousands by filing date
MELLANOX TECHNOLOGIES LTDM51363113COMMON STOCK165,000$19,529,000thousands by filing date
INTELSAT S AL5140P101COM1,231,500$19,285,000thousands by filing datecall
AVAYA HLDGS CORP05351X101COM1,104,510$18,589,000thousands by filing date
ELLIE MAE INC28849P100COM152,176$15,018,000thousands by filing date
QUINTANA ENERGY SVCS INC74875T103COM3,288,449$14,206,000thousands by filing date
iShares Russell 2000 ETF464287655SHS75,000$11,482,000thousands by filing date
Bristol-Myers Squibb Company110122108COM241,500$11,421,000thousands by filing date
BEMIS INC081437105COM163,619$9,078,000thousands by filing date
FOX CORP CL A COM35137L105Stock227,464$8,350,000thousands by filing date
KLA CORP482480100COM62,500$7,412,000thousands by filing date
HFF INC40418F108CL A153,300$7,320,000thousands by filing date
WABCO HLDGS INC92927K102COM43,000$5,669,000thousands by filing datecall
GOLDCORP INC NEW380956409COM100,000$1,144,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-19-001325this filing2019-05-15acceptance time not in the bulk data set